BioCentury
ARTICLE | Financial News

Aptevo completes debt financing

August 8, 2016 7:00 AM UTC

Aptevo Therapeutics Inc. (NASDAQ:APVO), Seattle, Wash. Business: Cancer, Hematology, Autoimmune Date completed: 2016-08-04 Type: Debt financing Raised: $20 million Investor: MidCap Financial Note: Apt...